Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
HONEYWELL AND CHEVRON COLLABORATE ON AI-ASSISTED SOLUTIONS FOR REFINING PROCESSES
-
OneRail Named to FreightWaves FreightTech 100 for Fourth Straight Year
-
Clear Start Tax Urges Taxpayers to Address Back Taxes Ahead of October Deadlines
-
ST Engineering Aethon Announces Winners of 2024 RoboHero Awards
-
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
-
Applebee’s Resurrects DOLLAR ZOMBIE for October Cocktail Special
-
Bloodshed Abounds in Staked! - a New Social Deduction Game Coming to Kickstarter Oct. 1
-
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
-
Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations
-
New CIRA data finds cyber crime is driving customers away from impacted Canadian businesses
-
Canadian Dermatology Association (CDA) Announces 2025 Shade Structure Grant Recipients
-
Canadian North Resources Continues Receiving the DIG Grant Awarded for its Successful Exploration Programs at Ferguson Lake Project
-
AllenComm and Pure Storage Win Gold in Brandon Hall Group's HCM Excellence Awards
-
First Student Launches First Services, Creating Comprehensive Expertise-Driven Offering for School Transportation Needs
-
HUB INTERNATIONAL ANNOUNCES STRATEGIC PARTNERSHIP WITH MAS SEGUROS TO EXPAND TRANSPORTATION CROSS-BORDER CAPABILITIES
-
NeuroBo Pharmaceuticals to Participate in Investor Conferences in October
-
HCLSoftware's Startup SYNC Announces First-Ever Startup Cohort Program Focused on Retail and E-commerce Innovation
-
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
-
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor
-
SolarBank's First Solar Project Under Development for Fiera Real Estate Nears Completion
-
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
-
Ben E. Keith Company Awards General Mills Supplier of the Year
-
Zero Layoffs in 99 Years: Torani Redefines What It Means to be a “People-First Company” as it Surpasses $500 Million in Annual Revenue
-
New ACS Report: Breast Cancer Mortality Continues Three Decade Decline Overall, but Steeper Increases in Incidence for Women <50 & Asian American, Pacific Islanders of all Ages
-
Enstar Completes Loss Portfolio Transfer With SiriusPoint
-
Axis Announces Merger with Brigade to Form the Premier Well Servicing Company in the U.S.
-
GroundWork Renewables and CFV Labs Join Forces to Expand Reference Data Offerings for the Solar Industry
-
TIPA to Unveil Expanded Portfolio of Zero-Waste Compostable Packaging Solutions at Pack Expo 2024
-
FlexShopper Files Patent Infringement Lawsuits Against Upbound Group, Inc. and Katapult Holdings, Inc.
-
Silver Spike Investment Corp. Completes Loan Portfolio Acquisition
-
Namale Resort & Spa Honored in Condé Nast Traveler's 2024 Readers' Choice Awards for Australia & South Pacific Resorts
-
Bitwave Receives Educational Grant from Arbitrum to Launch NASBA-Licensed Course Series for LATAM Finance Professionals
-
Equinix Agrees to Form Greater Than $15B JV to Expand Hyperscale Data Centers in the U.S. and Support Growing AI and Cloud Innovation
-
Rhymetec Strengthens Compliance Initiatives & Expands Team Amid Q3 Wins
-
Tennessee Oncology Expands Subspecialty Services By Adding Two Renowned Gynecological Oncologists
-
New AARP Pennsylvania Poll: Vice President Harris and Senator Casey Hold Narrow Leads in Presidential and U.S. Senate Races
-
Valvoline Great Canadian Oil Change Ranks Highest Among Aftermarket Service Facilities in J.D. Power Survey
-
SU Group Enters New Government Sponsored Market with Milestone Agreement
-
Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development
-
Wellcare to Offer Medicare Advantage and Medicare Prescription Drug Plans to More than 51 Million Members Nationwide in 2025
-
DDN Expands State-of-the-Art AI Research Footprint in Texas to Revolutionize Data-Driven Industries and Drive Economic Growth
-
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
-
ClariMed Inc. Strengthens Leadership Team with Joe Dobkin as New VP of Services
-
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
-
RTX to release third quarter results on October 22, 2024
-
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
-
TÜV Rheinland Expands Capabilities at Northeast Technology & Innovation Center for Household Appliances, Medical Equipment, and Laser Products
-
Eon Launches out of Stealth with $127 Million to Reinvent Cloud Infrastructure Backup
-
Alaska Airlines inaugurates service on five new routes
-
Calamos Announces Upside Cap Rates for CPSO and CPRO: Structured Protection ETFs Providing Exposure to S&P 500 and Russell 2000 with 100% Downside Protection Over One Year
